Factory CRO announced that it has acquired MileStone Research Organization. The financial details of the deal were not disclosed.
“The merger with MileStone is an important step in building Factory’s operational strength and service range in North America,” Dirk Meijer, Factory CRO’s CEO, said. “MileStone is an excellent fit therapeutically, as well as culturally, and complements our existing U.S. operations in Austin, Texas, and Princeton, N.J. Milestone’s extensive expertise in orthopedics, neurological and IVD clinical trials, as well as their reimbursement and site management service offerings, is a fantastic value-add for all our clients.”
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!